論文

国際誌
2023年

B cell receptor repertoire analysis from autopsy samples of COVID-19 patients.

Frontiers in immunology
  • Sadahiro Iwabuchi
  • Tomohide Tsukahara
  • Toshitugu Okayama
  • Masahiro Kitabatake
  • Hideki Motobayashi
  • Shigeyuki Shichino
  • Tadashi Imafuku
  • Kenzaburo Yamaji
  • Kyohei Miyamoto
  • Shinobu Tamura
  • Satoshi Ueha
  • Toshihiro Ito
  • Shin-Ichi Murata
  • Toshikazu Kondo
  • Kazuho Ikeo
  • Yutaka Suzuki
  • Kouji Matsushima
  • Michinori Kohara
  • Toshihiko Torigoe
  • Hiroki Yamaue
  • Shinichi Hashimoto
  • 全て表示

14
開始ページ
1034978
終了ページ
1034978
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3389/fimmu.2023.1034978

Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being developed world over. We investigated the possibility of producing artificial antibodies from the formalin fixation and paraffin-embedding (FFPE) lung lobes of a patient who died by coronavirus disease 2019 (COVID-19). The B-cell receptors repertoire in the lung tissue where SARS-CoV-2 was detected were considered to have highly sensitive virus-neutralizing activity, and artificial antibodies were produced by combining the most frequently detected heavy and light chains. Some neutralizing effects against the SARS-CoV-2 were observed, and mixing two different artificial antibodies had a higher tendency to suppress the virus. The neutralizing effects were similar to the immunoglobulin G obtained from healthy donors who had received a COVID-19 mRNA vaccine. Therefore, the use of FFPE lung tissue, which preserves the condition of direct virus sensitization, to generate artificial antibodies may be useful against future unknown infectious diseases.

リンク情報
DOI
https://doi.org/10.3389/fimmu.2023.1034978
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36911681
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996338
ID情報
  • DOI : 10.3389/fimmu.2023.1034978
  • PubMed ID : 36911681
  • PubMed Central 記事ID : PMC9996338

エクスポート
BibTeX RIS